Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GSK

SNDL Inc. (SNDL) vs. GSK plc (GSK): Analyzing the Better Long-Term Pharma Investment

Amid the burgeoning technological innovation and its seamless integration, investors' interest seems to gravitate toward the pharmaceutical industry. Keeping this in mind, which of the stocks, SNDL Inc. (SNDL) and GSK plc (GSK), could be a better long-term investment? Let's find out.

StockNews.com

Poor people in the developing world have a right to medicine

People should not die because of their income or where they were born. We must have the courage to stand up to the pharmaceutical industry

The Guardian - US

3 Pharma Stocks to Capitalize on With Potential Upside

The pharma industry’s prospects look bright, thanks to rising demand for innovative drugs. Thus, pharma stocks with potential upside, like GSK plc (GSK), Johnson & Johnson (JNJ), and Bristol-Myers Squibb Company (BMY), could be wise investments to capitalize on right now. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

We could see thunderstorm asthma in south-eastern Australia this season – here's how to prepare

Victorians have been warned to prepare for the possibility of thunderstorm asthma again this season.

The Conversation

3 Promising Pharma Stocks to Keep on Your Radar

The pharma industry’s prospects look bright, thanks to rising demand for generic and innovative drugs and technological advancements. Hence, adding fundamentally strong pharma stocks Astellas Pharma (ALPMY), Sanofi (SNY), and GSK (GSK) to one’s watchlist could be wise. Keep reading.

StockNews.com

Big Pharma slowed vaccine development

A vaccine against tuberculosis has never been closer to reality. But development slowed due to corporate interests

Salon

UN authorizes a second malaria vaccine. Experts warn it's not enough to stop the disease spreading

The World Health Organization has authorized a second malaria vaccine in a decision that could offer countries a cheaper and more effective option than the world’s first shot against the parasitic disease

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

People with HIV offered hope of self-injected drug at home

GSK-controlled company works on developing patient-administered treatment by end of the decade

The Guardian - UK

$A fractured UN is still notching wins with corporate sector$

A fractured UN is still notching wins with corporate sector

This week, the UN convinced companies to report new nature-related disclosures.

Fortune

3 Pharma Stocks for Value Investors

The aging global population and the growing demand for drugs and therapies to treat chronic diseases are boosting the long-term prospects of the pharmaceutical industry. Amid this backdrop, value investors could consider buying fundamentally strong pharma stocks GSK plc (GSK), Horizon Therapeutics (HZNP), and Neurocrine Biosciences (NBIX), as they are…

StockNews.com

More babies will need hospital treatment over RSV vaccine delay, says top doctor

The Medicines and Healthcare products Regulatory Agency (MHRA) approved GSK’s jab, known as Arexvy, for use among older adults in July.

The Independent UK

How Vivek Ramaswamy, the surprise GOP debate star, made his fortune and triggered his critics

He bills himself as an iconoclast ready to shake up the Republican Party after making millions trying to do the same in the biotech industry.

Fortune

Who should get the new RSV vaccines? Here's everything you need to know

There are now RSV vaccines approved for older adults and for pregnant people, and antibody shots (not vaccines) available for babies. What's the difference?

LiveScience

3 Pharma Stocks Investors Are Chasing for Value

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

An Under the Radar Healthcare Stock to Add to Your Portfolio

The era of the giant pharmaceutical conglomerate is coming to a close, but consumer-focused Haleon stock looks set to deliver healthy returns through long-term economic cycles.

Evening Standard

FTSE 100 Live: NatWest boss out, Ocado shares surge further, Fed ups rates but markets hope it’s last hike

The turmoil at NatWest, half-year figures by Lloyds and profit upgrades at GSK and Rolls-Royce are just some of today’s big blue-chip developments.

The Hindu

GSK leadership team meets KTR

The GSK team was excited to learn about the growth of the Lifesciences sector in Telangana and how global companies are leveraging the ecosystem.

The Guardian - UK

‘This feels exactly the right place to be’: Sir Patrick Vallance on pandemics, eco-anxiety and leading the Natural History Museum

The UK’s former chief scientific adviser, a familiar face during Covid, talks about his new role as chair of the London museum and putting its collection at the heart of our climate response

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Panadol maker plans sweeping job cuts a year after being spun off from GSK

Exclusive: Consumer healthcare firm Haleon to cut hundreds of roles in UK and potentially thousands globally

Evening Standard

RSV vaccine for over-60s on the horizon after regulatory approval

RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.

The Independent UK

Jab for common illness among over-60s on the horizon after regulatory approval

RSV (respiratory syncytial virus) leads to around 8,000 deaths among people aged over 60 in the UK every year.

Wales Online

New vaccine for disease that kills 8,000 over 60s in UK every year

The vaccine will help cut up to 175,000 GP visits

Daily Mirror

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

Evening Standard

Tech spending: The companies on London’s blue chip index exploring AI

A host of FTSE 100 companies are among businesses planning to invest in AI

The Independent UK

Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says

Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first

1 … 8 9 10 11

People

Tedros Adhanom Ghebreyesus

785 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.